The Assistance Fund Opens New Program for Myeloproliferative Neoplasms
Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Myeloproliferative Neoplasms ORLANDO, FLORIDA / ACCESS Newswire...
Heart Attack
Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)
FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial ESTERO, FL...
Life Line Screening (Updated): What You Need to Know?
New York City,, Jan. 01, 2026 (GLOBE NEWSWIRE) -- in 2026, The greatest way to stay healthy and avoid illnesses...
Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering
CHATHAM, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated...
Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field study Expect...
How Does Ozempic Work For Weight Loss? Best Weight Loss Supplement Launch By PhenQ
Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details – Best Weight Loss Supplement Phenq...
Novo Nordisk A/S: Wegovy® pill approved in the US as first oral GLP-1 for weight management
Wegovy® pill showed a mean weight loss of 16.6% in the OASIS 4 trial1Wegovy® pill is indicated to reduce excess...
Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss
The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability...
Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National...
New Hypertension publication underscores aprocitentan’s potential in managing hypertension patients with CKD
New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of aprocitentan in addition to...
New Hypertension publication underscores aprocitentan’s potential in managing hypertension patients with CKD
New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of aprocitentan in addition to...
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease
Interim data show substantial improvements in “Good On” time compared to other oral CD/LD therapiesCREXONT delivered substantial “Off” time reductions,...
Medi-Weightloss Celebrates 10 Million Pounds Lost, Improving Lives and Reducing Healthcare Costs
A leader in medically supervised weight management, proudly announces a major milestone: more than 10 million pounds lost collectively by...
Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a...
HealthTab™ to Power NHS Pilot
Bringing Cholesterol-Lowering Injections to U.K. Community PharmaciesVANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR)...
MyOme Launches First Integrated Polygenic Risk Score for Prostate Cancer to Advance Early Detection and Personalized Prevention
New whole-genome test uncovers hidden genetic risk beyond traditional screening, empowering earlier and more precise care for millions of men....
Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025
– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week – – Pivotal Phase 3 Launch-HTN trial featured in the...
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer...
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer...
NCH Becomes First U.S. Hospital to Use AI That Detects Hidden Heart Attack Risk a Decade in Advance
Landmark collaboration with Caristo Diagnostics positions NCH at the forefront of preventive cardiology NCH cardiologists to present collaboration plans at American...